The first found no significant difference in the incidence of moderate or severe OHSS (49), whilst the second reported that PPOS was associated with a lower risk of OHSS compared with a GnRH antagonist protocol (50). This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.